CLSH
CLS Holdings USA Inc
Price:  
0.03 
USD
Volume:  
85,580.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CLSH WACC - Weighted Average Cost of Capital

The WACC of CLS Holdings USA Inc (CLSH) is 5.4%.

The Cost of Equity of CLS Holdings USA Inc (CLSH) is 6.60%.
The Cost of Debt of CLS Holdings USA Inc (CLSH) is 6.60%.

Range Selected
Cost of equity 5.50% - 7.70% 6.60%
Tax rate 18.20% - 47.90% 33.05%
Cost of debt 6.20% - 7.00% 6.60%
WACC 5.3% - 5.5% 5.4%
WACC

CLSH WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.35 0.51
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.50% 7.70%
Tax rate 18.20% 47.90%
Debt/Equity ratio 1.2 1.2
Cost of debt 6.20% 7.00%
After-tax WACC 5.3% 5.5%
Selected WACC 5.4%

CLSH's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for CLSH:

cost_of_equity (6.60%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (0.35) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.